BacTech also reports that a total of 2,879,500 common share purchase warrants were exercised recently adding an additional $143,975 to the treasury.
BacTech also issued common share purchase warrants to certain individuals who previously agreed to extend their debentures for up to two years. A total of 8,444,000 warrants with an exercise price of $0.05 per warrant were issued with staggered expiry dates in 2022.
It is BacTech's intention to redeem these debentures either through repayment or conversion into common shares of the Company.
ABOUT BACTECH
BacTech is promoting the use of its proprietary bioleach processing technology to treat historic arsenopyrite concentrates and tailings produced in the Ponce Enriquez area of Southern Ecuador. The Company is also awaiting the reduction in government imposed Covid restrictions in Colombia where BacTech will investigate a gold/platinum tailings project.
For further information contact:
Ross Orr,
President & CEO, BacTech Environmental Corporation
416-813-0303 ext. 222,
Cell 416-346-5529 and
Email: [email protected]
Website: www.bactechgreen.com
Follow us on:
Facebook http://www.facebook.com/BacTechGreen
Twitter http://twitter.com/BacTechGreen
LinkedIn http://www.linkedin.com/company/1613873
Vimeo http://vimeo.com/bactechgreen
YouTube http://www.youtube.com/user/bactechgreen
Special Note Regarding Forward-Looking Statements
Shares outstanding: 132,310,538
The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the shares, nor is it a solicitation of interest from a prospective investor.
Copyright (c) 2021 TheNewswire - All rights reserved.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
